000 | 01969 a2200565 4500 | ||
---|---|---|---|
005 | 20250517031616.0 | ||
264 | 0 | _c20160412 | |
008 | 201604s 0 0 eng d | ||
022 | _a1432-0533 | ||
024 | 7 |
_a10.1007/s00401-015-1426-z _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPreisner, Anna | |
245 | 0 | 0 |
_aNon-steroidal anti-inflammatory drug indometacin enhances endogenous remyelination. _h[electronic resource] |
260 |
_bActa neuropathologica _cAug 2015 |
||
300 |
_a247-61 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xpharmacology |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 | _aCell Line, Tumor |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCerebellum _xdrug effects |
650 | 0 | 4 | _aCuprizone |
650 | 0 | 4 |
_aDemyelinating Diseases _xdrug therapy |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndomethacin _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aMyelin Sheath _xdrug effects |
650 | 0 | 4 |
_aNeural Stem Cells _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 |
_aOligodendroglia _xdrug effects |
650 | 0 | 4 | _aTissue Culture Techniques |
650 | 0 | 4 |
_aWnt Signaling Pathway _xdrug effects |
700 | 1 | _aAlbrecht, Stefanie | |
700 | 1 | _aCui, Qiao-Ling | |
700 | 1 | _aHucke, Stephanie | |
700 | 1 | _aGhelman, Julia | |
700 | 1 | _aHartmann, Christine | |
700 | 1 | _aTaketo, Makoto Mark | |
700 | 1 | _aAntel, Jack | |
700 | 1 | _aKlotz, Luisa | |
700 | 1 | _aKuhlmann, Tanja | |
773 | 0 |
_tActa neuropathologica _gvol. 130 _gno. 2 _gp. 247-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00401-015-1426-z _zAvailable from publisher's website |
999 |
_c24871195 _d24871195 |